The Weill Cornell Medicine Program for Substance Use and Stigma of Addiction, under the leadership of Dr. Jonathan Avery, Vice Chair for Addiction Psychiatry at Weill Cornell Medicine, has proudly distributed naloxone rescue kits (Narcan) to the New York City community for 10 years.
In this video episode of On the Mind, our host and Weill Cornell Medicine General Psychiatry Residency Director, Dr. Daniel Knoepflmacher, meets with two second year residents, Drs. Maya Graves and Nathen Spitz, for an inside look at residency training.
The Weill Cornell Medicine Department of Psychiatry is delighted to announce that Avital Falk, Ph.D., has been appointed the Director of a new Division of Digital and Treatment Innovations and the Director of Child and Adolescent Psychology. As director, Dr. Falk will be responsible for building and overseeing a centralized hub for faculty and trainees to gain mentorship and support in the development, dissemination and study of novel digital tools and psychotherapeutic treatments.
The Weill Cornell Medicine Department of Psychiatry is happy to announce that Amanda Wallace, M.D., assistant professor of clinical psychiatry at Weill Cornell Medicine, will join the child and adolescent psychiatry training leadership team. As of March 1, 2024, Dr.
Providing a space of shared strength and resilience for our Weill Cornell Medicine community, the Department of Psychiatry has responded swiftly to provide support in the face of tragedy. Immediate support efforts included live support groups for our internal Weill Cornell Medicine community, hosted by Drs. Stephanie Cherestal and Judith Cukor.
In March of 2023, the FDA's approval of Naloxone, often referred to as Narcan, for over-the-counter sale marked a pivotal decision for treating the opioid epidemic in the United States. While barriers still exist in ensuring widespread access to this life-saving medication, the immediate implications of this regulatory change cannot be underestimated.
In the wake of the terrorist attack in Israel and the ensuing war in Gaza, as well as terrorism and violence around the world and in our communities, the Center for Youth Mental Health at NewYork-Presbyterian Hospital has created a guide to help you and your family with having difficult conversations and coping with tragedies.
To spread awareness about suicide prevention, the Weill Cornell Medicine Department of Psychiatry is partnering with our colleagues in medicine to spread prevention awareness to different communities. To learn more about how to spread awareness or provide support to yourself or someone in need, we invite you to explore our resources, follow us on social media and attend our suicide prevention month events.
Substance use disorders and the stigma surrounding addiction continue to be pressing issues in society, particularly in relation to the devastating impact of opioid addiction. Weill Cornell Medicine is dedicated to combating these challenges through its Program for Substance Use and Stigma of Addiction. Led by Dr. Jonathan Avery, Vice Chair for Addiction Psychiatry, the program aims to diminish the stigma associated with addiction while enhancing the lives of those affected.
May is a significant month for mental health advocates and professionals alike, as it marks both Mental Health Awareness Month and Borderline Personality Disorder (BPD) Awareness Month. With the aim of promoting understanding, reducing stigma and emphasizing the importance of mental well-being, these observances serve as powerful reminders of the ongoing work needed to support individuals facing mental health challenges.
